BRAF INHIBITORS PA SUMMARY MEDICATIONS: Mekinist, Tafinlar ...
BRAF INHIBITORS PA SUMMARY MEDICATIONS: Mekinist, Tafinlar, Zelboraf LENGTH OF AUTHORIZATION: 1 Year PA CRITERIA: For Mekinist Approvable for the diagnosis of unresectable or metastatic melanoma AND Member must have a BRAF V600E or V600K mutation as detected by an FDA-approved test, ... Get Document
Vemurafenib And BRAF Inhibition: A New Class Of Treatment For ...
2 Abstract: The United States Food and Drug Administration recently approved vemurafenib for the treatment of BRAF V600E mutant metastatic melanoma. ... View Full Source
Immunohistochemistry Is Highly Sensitive And Specific For The ...
Melanoma,5 colorectal cancer,6,7 and papillary thyroid carcinoma.8,9 Potent inhibitors of V600 mutant BRAF have revolutionized the treatment of metastatic melano- ... Get Doc
No comments:
Post a Comment